MHTX.US Manhattan Scients

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Oct 14, 2026
Market cap
USD 55.9K
P/E
-
P/B
15.64x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2024.

Is MHTX.US undervalued?

Graham number

The Graham number of Manhattan Scients cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Manhattan Scients fundamental analysis

No fundamental analysis for Manhattan Scients yet.

Manhattan Scients stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Manhattan Scients

Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc.…

Full company profile